243 related articles for article (PubMed ID: 23183180)
1. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age.
Maliqueo M; Sun M; Johansson J; Benrick A; Labrie F; Svensson H; Lönn M; Duleba AJ; Stener-Victorin E
Endocrinology; 2013 Jan; 154(1):434-45. PubMed ID: 23183180
[TBL] [Abstract][Full Text] [Related]
2. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
3. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
[TBL] [Abstract][Full Text] [Related]
4. Acupuncture does not ameliorate metabolic disturbances in the P450 aromatase inhibitor-induced rat model of polycystic ovary syndrome.
Maliqueo M; Benrick A; Marcondes RR; Johansson J; Sun M; Stener-Victorin E
Exp Physiol; 2017 Jan; 102(1):113-127. PubMed ID: 27790765
[TBL] [Abstract][Full Text] [Related]
5. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats.
Patel R; Shah G
Reproduction; 2018 Feb; 155(2):141-151. PubMed ID: 29196492
[TBL] [Abstract][Full Text] [Related]
6. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Ryan GE; Malik S; Mellon PL
Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
Mitwally MF; Casper RF
J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
[TBL] [Abstract][Full Text] [Related]
8. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
9. Kisspeptin expression features in the arcuate and anteroventral periventricular nuclei of hypothalamus of letrozole-induced polycystic ovarian syndrome in rats.
Aliabadi E; Namavar MR; Mortezaee K; Toolee H; Keshtgar S; Mirkhani H; Akbari M; Rastegar T; Solhjoo S
Arch Gynecol Obstet; 2017 Nov; 296(5):957-963. PubMed ID: 28875319
[TBL] [Abstract][Full Text] [Related]
10. Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.
Cao SF; Hu WL; Wu MM; Jiang LY
Reprod Sci; 2017 Mar; 24(3):456-462. PubMed ID: 27407136
[TBL] [Abstract][Full Text] [Related]
11. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease.
Kafali H; Iriadam M; Ozardali I; Demir N
Arch Med Res; 2004; 35(2):103-8. PubMed ID: 15010188
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats.
Ullah A; Jahan S; Razak S; Pirzada M; Ullah H; Almajwal A; Rauf N; Afsar T
J Ovarian Res; 2017 Sep; 10(1):62. PubMed ID: 28915843
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
14. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
[TBL] [Abstract][Full Text] [Related]
15. Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat.
Pandey V; Singh A; Singh A; Krishna A; Pandey U; Tripathi YB
Reprod Biol; 2016 Mar; 16(1):70-7. PubMed ID: 26952756
[TBL] [Abstract][Full Text] [Related]
16. Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat.
Zurvarra FM; Salvetti NR; Mason JI; Velazquez MM; Alfaro NS; Ortega HH
Reprod Fertil Dev; 2009; 21(7):827-39. PubMed ID: 19698287
[TBL] [Abstract][Full Text] [Related]
17. Welsh Onion Root (
Lee YH; Yang H; Lee SR; Kwon SW; Hong EJ; Lee HW
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30287740
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone.
Rezvanfar MA; Rezvanfar MA; Ahmadi A; Saadi HA; Baeeri M; Abdollahi M
Hum Exp Toxicol; 2012 Sep; 31(9):887-97. PubMed ID: 22076494
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular mechanisms of pentoxifylline's beneficial effects in experimental polycystic ovary.
Rezvanfar MA; Saadat S; Shojaei Saadi HA; Mansoori P; Saeedi S; Gooshe M; Baeeri M; Abdollahi M
Theriogenology; 2015 Apr; 83(6):968-77. PubMed ID: 25557188
[TBL] [Abstract][Full Text] [Related]
20. Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome.
Bukke SPN; Pathange BBR; Karumanchi SK; Marri J; Boyina R; Rachamsetty K; Manchikalapati B; Odoma S; Hussaini B
J Ovarian Res; 2023 Nov; 16(1):221. PubMed ID: 37993900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
